Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
Completed · Phase 2 · Has a placebo group
Conditions studied: Fibromyalgia
In brief
To evaluate the efficacy of NYX-2925 versus placebo for the treatment of fibromyalgia.
Key facts
- Study ID
- NCT04147858
- Run by
- Aptinyx
- People needed
- 310
- Starts
- 2019-11-12
- Expected to finish
- 2022-06-16
- Last updated by the study team
- 2023-04-28
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Informed consent
- Subject has a history of fibromyalgia that was diagnosed >1 year prior to screening and reports at least moderate pain over the last week
- Stable protocol allowed medication and other therapies during the study
- Agrees to use highly effective birth control during the study
- Has not participated in an interventional study for at least 30 days and agrees not to participate in another interventional study during the study
You may not qualify if…
- Pain due to other conditions or diseases that would complicate participation in the study or pain reporting
- Current or historical serious medical conditions
- Prior participation in NYX-2925 clinical trial
Where it is running
- Aptinyx Clinical Site — Phoenix, Arizona, United States
- Aptinyx Clinical Site — Culver City, California, United States
- Aptinyx Clinical Site — Fresno, California, United States
- Aptinyx Clinical Site — Orange, California, United States
- Aptinyx Clinical Site — Redlands, California, United States
- Aptinyx Clinical Site — Temecula, California, United States
- Aptinyx Clinical Site — Torrance, California, United States
- Aptinyx Clinical Site — Fernandina Beach, Florida, United States
- Aptinyx Clinical Site — Jacksonville, Florida, United States
- Aptinyx Clinical Site — Jacksonville, Florida, United States
- Aptinyx Clinical Site — Lady Lake, Florida, United States
- Aptinyx Clinical Site — Miami, Florida, United States
- Aptinyx Clinical Site — Orlando, Florida, United States
- Aptinyx Clinical Site — Palmetto Bay, Florida, United States
- Aptinyx Clinical Site — Winter Park, Florida, United States
- Aptinyx Clinical Site — Alpharetta, Georgia, United States
- Aptinyx Clinical Site — Chicago, Illinois, United States
- Aptinyx Clinical Site — Flossmoor, Illinois, United States
- Aptinyx Clinical Site — Gurnee, Illinois, United States
- Aptinyx Clinical Site — Skokie, Illinois, United States
- Aptinyx Clinical Site — Evansville, Indiana, United States
- Aptinyx Clinical Site — West Des Moines, Iowa, United States
- Aptinyx Clinical Site — Newton, Kansas, United States
- Aptinyx Clinical Site — Prairie Village, Kansas, United States
- Aptinyx Clinical Site — Wichita, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.